Another breakthrough in obesity treatment. After 80 weeks of retatrutide, mean weight loss reached 25%, with additional benefits including less knee pain and fewer sleep apnea episodes. At 12 mg/week, weight loss was 28.3%, and 45.3% achieved ≥30% weight loss. https://t.co/jeL475XMHX #Obesity #WeightLoss #Health #Nospecificcountriesarementionedinthetweet.Therefore #therearenocountrycodestoreturn.

